
Darbecure 40 Injection
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Darbepoetin alfa (40mcg)
Overview Darbecure 40 Injection
Erythropoiesis-stimulating agent Darbecure 40 Injection treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation for increased red blood cell production. Due to potential serious adverse effects, administration requires rigorous caution and oversight by a qualified hematologist. Strict adherence to the physician's instructions is mandatory, as this medication is administered only under professional medical supervision. Frequently reported side effects encompass abdominal discomfort, hypertension, cutaneous eruptions, injection site pain, dyspnea, cough, and peripheral swelling. Report immediately any signs of severe hypertension, such as intense headache, visual disturbances, emesis, nausea, or convulsions. Regular blood tests, monitoring electrolyte levels (potassium), hemoglobin, and blood cell counts, are typically ordered by the prescribing physician. Discontinue use and seek immediate medical attention if shortness of breath or a skin rash develops. Prior to initiating therapy, disclose any pre-existing cardiac conditions, hypertension, history of seizures or stroke. Pregnant, breastfeeding, or intending to conceive or breastfeed individuals must consult their physician regarding the medication's safety profile.
Uses of Darbecure 40 Injection
Managing anemia in patients with chronic kidney disease | Addressing chemotherapy-induced anemia
Major Benefits of Darbecure 40 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Darbecure 40 Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Darbecure 40 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Darbecure 40 Injection works:
Darbecure 40 Injection, an erythropoietin-based medication, boosts red blood cell production. This action occurs through stimulation of the bone marrow, the blood cell-generating tissue within bones.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Darbecure 40 Injection may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Darbecure 40 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Limited evidence indicates that Darbecure 40 Injection may pose a risk to breastfeeding infants. The drug's potential transfer into breast milk, and consequent harm to the baby, necessitates caution.
DrivingSAFE
Driving ability is typically unaffected by Darbecure 40 Injection.
KidneySAFE IF PRESCRIBED
Darbecure 40 Injection poses no safety concerns for patients with kidney impairment; no dosage modification is necessary.
LiverCAUTION
For individuals with hepatic impairment, Darbecure 40 Injection requires careful administration. Dosage modification of Darbecure 40 Injection might be necessary. Physician consultation is advised.
What if you forget to take Darbecure 40 Injection :
Should you forget a Darbecure 40 Injection dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Darbecure 40 Injection
Label | Value |
---|---|
Chemical Category | Amino Acid and Peptide Analogs |
Developing Habits | No. |
Treatment Category | KINSHIP |
Behavior Class | Erythropoietin-stimulating drug |